These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34819242)

  • 1. A Comparison of Coagulation Function in Patients Receiving Aspirin and Cefoperazone-Sulbactam With and Without Vitamin K
    Wu S; Wu G; Wu H
    Clin Ther; 2021 Dec; 43(12):e335-e345. PubMed ID: 34819242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Cefoperazone/Sulbactam on Blood Coagulation Function in Infected Emergency Department Patients and the Necessity of Vitamin K1 (VK1) Preventive Intervention: A Single-Center, Retrospective Analysis.
    Shao X; Ren Y; Xie N; Fan K; Sun H; Lu J; Wei J; Tian X
    Med Sci Monit; 2023 Jun; 29():e939203. PubMed ID: 37271979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study.
    Wang W; Liu Y; Yu C; Tan J; Xiong W; Dong D; Li S; Zhang R; Li J; Wu Y; Zong Z; Su N; Zou K; Wu G; Sun X
    Expert Opin Drug Saf; 2020 Mar; 19(3):339-347. PubMed ID: 31914329
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies.
    Zhang L; Cai X; Peng F; Tian S; Wu X; Li Y; Guo J
    Front Pharmacol; 2023; 14():1182644. PubMed ID: 37351509
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics and Influencing Factors of Coagulation Dysfunction Caused by Cefoperazone/Sulbactam.
    Zeng J; Zou M; Min M; Xu M
    Altern Ther Health Med; 2024 Sep; 30(9):274-278. PubMed ID: 38290444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Cefoperazone/Sulbactam-Induced Coagulation Disorder.
    Miao W; Guo J; Cheng H; Zhao Q
    Infect Drug Resist; 2023; 16():6277-6284. PubMed ID: 37766881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature.
    Cai Z; Yang W; He Y; Chen Q; Wang S; Luo X; Wang X
    Drug Saf Case Rep; 2016 Dec; 3(1):2. PubMed ID: 27747682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis use of vitamin K1 improves coagulation function in hematopoietic stem cell transplantation patients: a retrospective cohort study.
    Zhang Y; Lu X; Tang LV
    Am J Transl Res; 2022; 14(3):1729-1736. PubMed ID: 35422932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Vitamin K1 for the Correction of Prolonged Prothrombin Times in Non-Bleeding Critically Ill Patients: A Prospective Observational Study.
    Dahlberg S; Schött U; Eriksson EÄ; Tahirsylaj Y; Schurgers L; Kander T
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.
    Hu J; Xiao YH; Zheng Y; Lai YX; Fang XL; Fang Q
    Eur J Clin Pharmacol; 2020 Jul; 76(7):913-922. PubMed ID: 32355990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and internal validation of a model for predicting cefoperazone/sulbactam-associated coagulation disorders in Chinese inpatients.
    Fu A; Ge F; Wang Y; Guo H; Zhu M; Li S; Gao A; Li C; Lu J; Guo D
    BMC Pharmacol Toxicol; 2024 Jul; 25(1):41. PubMed ID: 38997770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.
    Stettler GR; Moore EE; Moore HB; Nunns GR; Coleman JR; Colvis A; Ghasabyan A; Cohen MJ; Silliman CC; Banerjee A; Sauaia A
    J Trauma Acute Care Surg; 2019 Sep; 87(3):582-589. PubMed ID: 31136528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation.
    Greenberg RN; Reilly PM; Weinandt WJ; Bollinger M; Kennedy DJ
    Clin Ther; 1987; 10(1):52-6. PubMed ID: 3329965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
    Kochhar P; Suvarna V; Duttagupta S; Sarkar S
    Value Health; 2008 Mar; 11 Suppl 1():S33-8. PubMed ID: 18387065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers.
    Weitekamp MR; Caputo GM; Al-Mondhiry HA; Aber RC
    J Antimicrob Chemother; 1985 Jul; 16(1):95-101. PubMed ID: 4044467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perioperative changes of coagulation functions in the local advanced liver cancer patients receiving liver transplantation].
    Wang HY; Zhao QY; Yuan YF
    Ai Zheng; 2008 Jul; 27(7):743-7. PubMed ID: 18606069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding the optimal dose of vitamin K1 to treat vitamin K deficiency and to avoid anaphylactoid reactions.
    Mi YN; Ping NN; Li B; Xiao X; Zhu YB; Cao L; Ren JK; Cao YX
    Fundam Clin Pharmacol; 2017 Oct; 31(5):495-505. PubMed ID: 28407450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant
    Niu T; Luo Q; Li Y; Zhou Y; Yu W; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():52. PubMed ID: 30886705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefoperazone-induced Coagulopathy in Critically Ill Patients Admitted to Intensive Care Unit.
    Gudivada KK; Krishna B; Sampath S
    Indian J Crit Care Med; 2023 Mar; 27(3):183-189. PubMed ID: 36960109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.